Morinaga Milk Industry Co Ltd
TSE:2264
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 5-Year Average (12.7), the stock would be worth ¥3 769.17 (20% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 15.9 | ¥4 739 |
0%
|
| 5-Year Average | 12.7 | ¥3 769.17 |
-20%
|
| Industry Average | 27.8 | ¥8 260.72 |
+74%
|
| Country Average | 22.4 | ¥6 654.14 |
+40%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Morinaga Milk Industry Co Ltd
TSE:2264
|
384.3B JPY | 15.9 | 30.4 | |
| JP |
G
|
Goyo Foods Industry Co Ltd
TSE:2230
|
53.2T JPY | -621 880.5 | 540 752.8 | |
| CH |
|
Nestle SA
SIX:NESN
|
203.3B CHF | 28.5 | 22.5 | |
| US |
|
Mondelez International Inc
NASDAQ:MDLZ
|
78.7B USD | 15.9 | 32.1 | |
| FR |
|
Danone SA
PAR:BN
|
42.7B EUR | 15.3 | 23.5 | |
| ZA |
T
|
Tiger Brands Ltd
JSE:TBS
|
47.6B ZAR | 347.5 | 12.5 | |
| US |
|
Hershey Co
NYSE:HSY
|
37B USD | 19.6 | 41.9 | |
| CN |
|
Muyuan Foods Co Ltd
SZSE:002714
|
244.2B CNY | -46.5 | 25 | |
| ZA |
A
|
Avi Ltd
JSE:AVI
|
33.1B ZAR | 16.6 | 12.8 | |
| CN |
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
225.7B CNY | 35.9 | 32.1 | |
| CH |
|
Chocoladefabriken Lindt & Spruengli AG
SIX:LISN
|
23.2B CHF | 198.9 | 31.9 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 14.9 |
| Median | 22.4 |
| 70th Percentile | 35 |
| Max | 736 044 589.7 |
Other Multiples
Morinaga Milk Industry Co Ltd
Glance View
In the bustling heart of Japan's industrious dairy sector, Morinaga Milk Industry Co., Ltd. stands as a testament to over a century of innovation and commitment to quality. Founded in 1917, the company has woven itself into the fabric of everyday Japanese life, evolving to meet the dietary demands of diverse consumers. From humble beginnings, Morinaga has expanded beyond simple milk production to embrace a broad spectrum of dairy products, including yogurt, cheese, and infant formula. Their offerings not only satisfy traditional tastes but also cater to contemporary health-conscious lifestyles, as evidenced by their investment in functional foods containing probiotics and other beneficial bacteria. These specialized products not only enhance everyday wellness, but they also carve out a profitable niche within a competitive market. The company's ethos remains steadfast: combining tradition with innovation to deliver health-focused dairy solutions. At the core of Morinaga's business model is a sophisticated distribution network and a robust brand portfolio that captures significant market share across various segments. Their wide-reaching distribution channels enable the efficient delivery of products to supermarkets, convenience stores, and food service companies both domestically and internationally. By strategically leveraging these channels, Morinaga ensures that its products are omnipresent, from local family dining tables to overseas markets thirsting for premium Japanese dairy. Importantly, Morinaga also derives income from licensing its technology, particularly in probiotic cultivation and applications, to other companies – a move that underscores its prowess in dairy innovation. This strategy not only enhances Morinaga's competitive edge but also diversifies its revenue streams, ultimately contributing to its resilient economic performance in the face of industry fluctuations.